Ceribell (CBLL) Cash & Equivalents (2023 - 2026)

Ceribell has reported Cash & Equivalents for 4 years, with the latest figure at $45.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 70.49% year-over-year to $45.3 million; the trailing twelve-month figure through Mar 2026 stood at $45.3 million (down 70.49% YoY), and the FY2025 full-year result was $40.5 million, down 79.18% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $45.3 million, up from $40.5 million in the prior quarter.
• The five-year high for Cash & Equivalents was $194.4 million in Q4 2024, with the low at $14.1 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $68.2 million across 4 years, with a median of $40.3 million in 2025.
• Annual changes were most pronounced in 2024 — Cash & Equivalents soared 463.47% — and 2025, when it plunged 79.18%.
• Ceribell's Cash & Equivalents stood at $34.5 million in 2023, then soared by 463.47% to $194.4 million in 2024, then sank by 79.18% to $40.5 million in 2025, then climbed by 11.8% to $45.3 million in 2026.
• The last three Cash & Equivalents figures came in at $45.3 million (Q1 2026), $40.5 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.